Cargando…

Expression of PD-1 and PD-L1 in Endometrial Cancer: Molecular and Clinical Significance

The landscape of diagnosing and treating endometrial cancer is undergoing a profound transformation due to the integration of molecular analysis and innovative therapeutic approaches. For several decades, the cornerstone treatments for endometrial cancer have included surgical resection, cytotoxic c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mamat @ Yusof, Mohd Nazzary, Chew, Kah Teik, Kampan, Nirmala Chandralega, Shafiee, Mohamad Nasir
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10607163/ https://www.ncbi.nlm.nih.gov/pubmed/37894913 http://dx.doi.org/10.3390/ijms242015233

Ejemplares similares

Efficacy and Safety of PD-1/PD-L1 Inhibitor as Single-Agent Immunotherapy in Endometrial Cancer: A Systematic Review and Meta-Analysis
por: Mamat @ Yusof, Mohd Nazzary, et al.
Publicado: (2023)

PD-L1 Expression in Endometrial Cancer and Its Association with Clinicopathological Features: A Systematic Review and Meta-Analysis
por: Mamat @ Yusof, Mohd Nazzary, et al.
Publicado: (2022)

Where are we going with sentinel nodes mapping in ovarian cancer?
por: Kampan, Nirmala Chandralega, et al.
Publicado: (2022)

New Predictive Biomarkers for Ovarian Cancer
por: Atallah, Ghofraan Abdulsalam, et al.
Publicado: (2021)

Perception and knowledge of human papillomavirus (HPV) vaccine for cervical cancer prevention among fully vaccinated female university students in the era of HPV vaccination: a cross-sectional study
por: Chew, Kah Teik, et al.
Publicado: (2021)

The impact of the COVID-19 pandemic on the national HPV immunization program in Malaysia
por: Rao, Sharvina Ramesh, et al.
Publicado: (2022)

Predicting Prognosis and Platinum Resistance in Ovarian Cancer: Role of Immunohistochemistry Biomarkers
por: Atallah, Ghofraan Abdulsalam, et al.
Publicado: (2023)

Prognostic Value of TNFR2 and STAT3 among High-Grade Serous Ovarian Cancer Survivors According to Platinum Sensitivity
por: Silva Raju, Janisha, et al.
Publicado: (2021)

Sexual functioning and marital satisfaction among endometriosis patients in Malaysia: a cross-sectional study
por: Rao, Sharvina Ramesh, et al.
Publicado: (2023)

Sexual Dysfunction among Gynaecological Cancer Survivors: A Descriptive Cross-Sectional Study in Malaysia
por: Mohamad Muhit, Akmal Muzamir, et al.
Publicado: (2022)

Management of Menstrual Disorder in Adolescent Girls with Intellectual Disabilities: A Blessing or a Curse?
por: Nurkhairulnisa, Abu Ishak, et al.
Publicado: (2018)

Successful External Cephalic Version: Factors Predicting Vaginal Birth
por: Lim, Pei Shan, et al.
Publicado: (2014)

PD-L1 Expression in Endometrial Serous Carcinoma and Its Prognostic Significance
por: Zhang, Tao, et al.
Publicado: (2021)

Tumor-TME Bipartite Landscape of PD-1/PD-L1 in Endometrial Cancers
por: Sulaiman, Raed, et al.
Publicado: (2023)

Expression of PD-1, PD-L1 and PD-L2 is associated with differentiation status and histological type of endometrial cancer
por: Mo, Zhongfu, et al.
Publicado: (2016)

The significance of PD-1/PD-L1 imbalance in ulcerative colitis
por: Shi, Wei, et al.
Publicado: (2023)

Biological Characteristics and Clinical Significance of Soluble PD-1/PD-L1 and Exosomal PD-L1 in Cancer
por: Niu, Mengke, et al.
Publicado: (2022)

Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
por: Zhu, Xinxin, et al.
Publicado: (2017)

Comparison of PD-L1 immunohistochemical assays and the significance of PD-L1 expression in thymoma
por: Yokoyama, Shintaro, et al.
Publicado: (2020)

Regulation of PD-1/PD-L1 pathway and resistance to PD-1/PD-L1 blockade
por: Bai, Jie, et al.
Publicado: (2017)

The impact of single agent PD-1 or PD-L1 inhibition on advanced endometrial cancers: meta-analysis
por: Kok, P.-S., et al.
Publicado: (2022)

Molecular mechanism of PD-1/PD-L1 blockade via anti-PD-L1 antibodies atezolizumab and durvalumab
por: Lee, Hyun Tae, et al.
Publicado: (2017)

Significance of Detection of the HER2 Gene and PD-1/PD-L1 in Gastric Cancer
por: Yun, Tian, et al.
Publicado: (2020)

BRAF V600E Mutation in Ameloblastoma: A Systematic Review and Meta-Analysis
por: Mamat @ Yusof, Mohd Nazzary, et al.
Publicado: (2022)

PD-1 inhibitors in endometrial cancer
por: Barroso-Sousa, Romualdo, et al.
Publicado: (2017)

PD-L1 Nanobody Competitively Inhibits the Formation of the PD-1/PD-L1 Complex: Comparative Molecular Dynamics Simulations
por: Sun, Xin, et al.
Publicado: (2018)

Molecular Mechanism of Small-Molecule Inhibitors in Blocking the PD-1/PD-L1 Pathway through PD-L1 Dimerization
por: Guo, Yan, et al.
Publicado: (2021)

Clinical Implication of PD-L1 Expression in Patients with Endometrial Cancer
por: Kim, Yeorae, et al.
Publicado: (2023)

Dedifferentiated Endometrial Carcinoma Could be A Target for Immune Checkpoint Inhibitors (Anti PD-1/PD-L1 Antibodies)
por: Ono, Ruriko, et al.
Publicado: (2019)

Basis of PD1/PD-L1 Therapies
por: Seliger, Barbara
Publicado: (2019)

Therapeutic PD-L1 antibodies are more effective than PD-1 antibodies in blocking PD-1/PD-L1 signaling
por: De Sousa Linhares, Annika, et al.
Publicado: (2019)

Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
por: Diggs, Laurence P., et al.
Publicado: (2017)

Molecular Modeling Studies on the Binding Mode of the PD-1/PD-L1 Complex Inhibitors
por: Almahmoud, Suliman, et al.
Publicado: (2019)

Rational development of molecularly imprinted nanoparticles for blocking PD-1/PD-L1 axis
por: Gu, Zikuan, et al.
Publicado: (2022)

Significance of PD-L1 Expression in Tongue Cancer Development
por: Yoshida, Saori, et al.
Publicado: (2018)

PD-1/PD-L1 Inhibitors in Cervical Cancer
por: Liu, Yuncong, et al.
Publicado: (2019)

PD-L1/PD-1 Axis in Glioblastoma Multiforme
por: Litak, Jakub, et al.
Publicado: (2019)

A snapshot of the PD-1/PD-L1 pathway
por: Ghosh, Chinmoy, et al.
Publicado: (2021)

The PD-1:PD-L1 axis in Inflammatory Arthritis
por: Canavan, Mary, et al.
Publicado: (2021)

An update on immunotherapy with PD-1 and PD-L1 blockade
por: Koh, Sung Ae
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ei0bbt0888i74rsbr03tblk3rq